CONCENTRATIONS

12 Months Ended

Dec. 31, 2018

(12)

CONCENTRATIONS

The Company’s is exposed to concentration of credit risk related primarily to its cash balances. The Company maintains its cash at major financial institutions. The Company has not experienced any realized losses in such accounts and believes it is not exposed to any significant credit risk related to its cash.

The Company has one major vendor from which is sourced approximately 49% of supplies and components for its electrotherapy products for the year ended December 31, 2018. The same vendor provided approximately 45% of supplies and components for the year ended December 31, 2017. Management believes that its relationships with its suppliers are very good; The Company has established credit terms with many vendors after several years of delayed and extended payments for cash flow reasons. If the relationships were to be replaced, there may be a short-term disruption to operations, a period of time in which products may not be available and additional expenses may be incurred.

The Company had receivables from a private health insurance carrier at December 31, 2018 and 2017, which made up approximately

% and

%, respectively, of the net accounts receivable balance.